Otonomy, Inc. (OTIC) financial statements (2020 and earlier)

Company profile

Business Address 4796 EXECUTIVE DRIVE
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:616879879793100
Cash and cash equivalents25161216342119
Short-term investments35526671647181
Other undisclosed cash, cash equivalents, and short-term investments000(0)00(0)
Receivables0000000
Prepaid expense2312222
Other undisclosed current assets0001000
Total current assets:6372808910095102
Noncurrent Assets
Operating lease, right-of-use asset15   
Property, plant and equipment4444445
Restricted cash and investments1111111
Other noncurrent assets  00000
Other undisclosed noncurrent assets 161616   
Total noncurrent assets:20202121556
TOTAL ASSETS:8392101110105100108
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9887775
Accounts payable1121111
Accrued liabilities5544443
Employee-related liabilities3221322
Debt3      
Deferred rent credit    000
Other undisclosed current liabilities 333   
Total current liabilities:12111110776
Noncurrent Liabilities
Long-term debt and lease obligation3015151515  
Long-term debt, excluding current maturities1515151515  
Finance lease, liability0   
Operating lease, liability15   
Liabilities, other than long-term debt    333
Deferred rent credit    333
Other undisclosed noncurrent liabilities 161616   
Total noncurrent liabilities:303131311833
Total liabilities:4341424125108
Stockholders' equity
Stockholders' equity attributable to parent405159698090100
Common stock0000000
Additional paid in capital500500498496495492490
Accumulated other comprehensive income (loss)0000(0)(0)(0)
Accumulated deficit(460)(449)(439)(427)(415)(402)(390)
Total stockholders' equity:405159698090100
TOTAL LIABILITIES AND EQUITY:8392101110105100108

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues0000000
Cost of revenue
(Cost of Goods and Services Sold)
(0)(0)(0)(0)(0)(0)(0)
Gross profit:(0)(0)(0)(0)(0)(0)(0)
Operating expenses(11)(10)(12)(12)(13)(13)(14)
Operating loss:(11)(10)(12)(12)(13)(13)(14)
Interest and debt expense(0)(0)(0)(0)   
Other undisclosed income from continuing operations before equity method investments, income taxes0   2  
Loss before gain (loss) on sale of properties:(11)(10)(12)(12)(12)(13)(14)
Other undisclosed net income (loss)0  1(1)  
Net loss:(11)(10)(12)(12)(13)(13)(14)
Other undisclosed net income attributable to parent 00  00
Net loss available to common stockholders, diluted:(11)(10)(12)(12)(13)(13)(14)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net loss:(11)(10)(12)(12)(13)(13)(14)
Comprehensive loss:(11)(10)(12)(12)(13)(13)(14)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)010000
Comprehensive loss, net of tax, attributable to parent:(11)(10)(12)(12)(13)(13)(14)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: